These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 24859886)
21. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α. Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114 [TBL] [Abstract][Full Text] [Related]
22. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread. Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399 [TBL] [Abstract][Full Text] [Related]
23. Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation. Hussain SS; Huang SB; Bedolla RG; Rivas P; Basler JW; Swanson GP; Hui-Ming Huang T; Narayanasamy G; Papanikolaou N; Miyamoto H; Yeh IT; Reddick RL; Pollock BH; Ghosh R; Kumar AP Cancer Lett; 2018 Oct; 433():232-241. PubMed ID: 30003927 [TBL] [Abstract][Full Text] [Related]
24. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3. Chen SY; Teng SC; Cheng TH; Wu KJ Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472 [TBL] [Abstract][Full Text] [Related]
25. Induction, modulation and potential targets of miR-210 in pancreatic cancer cells. Chen WY; Liu WJ; Zhao YP; Zhou L; Zhang TP; Chen G; Shu H Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):319-24. PubMed ID: 22672828 [TBL] [Abstract][Full Text] [Related]
26. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532 [TBL] [Abstract][Full Text] [Related]
27. MiRNA-30e downregulation increases cancer cell proliferation, invasion and tumor growth through targeting RPS6KB1. Wang L; Ji XB; Wang LH; Xia ZK; Xie YX; Liu WJ; Qiu JG; Jiang BH; Liu LZ Aging (Albany NY); 2021 Nov; 13(21):24037-24049. PubMed ID: 34727092 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN. Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950 [TBL] [Abstract][Full Text] [Related]
29. miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer. Ling Z; Liu D; Zhang G; Liang Q; Xiang P; Xu Y; Han C; Tao T Oncol Rep; 2017 Sep; 38(3):1621-1628. PubMed ID: 29094170 [TBL] [Abstract][Full Text] [Related]
30. HIF-1α induces immune escape of prostate cancer by regulating NCR1/NKp46 signaling through miR-224. Chen CH; Li SX; Xiang LX; Mu HQ; Wang SB; Yu KY Biochem Biophys Res Commun; 2018 Sep; 503(1):228-234. PubMed ID: 29885835 [TBL] [Abstract][Full Text] [Related]
31. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture. Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370 [TBL] [Abstract][Full Text] [Related]
32. SNAIL gene inhibited by hypoxia-inducible factor 1α (HIF-1α) in epithelial ovarian cancer. Zhang P; Liu Y; Feng Y; Gao S Int J Immunopathol Pharmacol; 2016 Sep; 29(3):364-75. PubMed ID: 27044634 [TBL] [Abstract][Full Text] [Related]
33. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. García-Maceira P; Mateo J Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810 [TBL] [Abstract][Full Text] [Related]
34. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6). Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557 [TBL] [Abstract][Full Text] [Related]
35. Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells. Befani CD; Vlachostergios PJ; Hatzidaki E; Patrikidou A; Bonanou S; Simos G; Papandreou CN; Liakos P J Mol Med (Berl); 2012 Jan; 90(1):45-54. PubMed ID: 21909688 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII. Zhang W; Liu J; Qiu J; Fu X; Tang Q; Yang F; Zhao Z; Wang H Oncol Rep; 2016 Dec; 36(6):3707-3715. PubMed ID: 27748848 [TBL] [Abstract][Full Text] [Related]
37. The role of hypoxia-inducible factor-1α and -2α in androgen insensitive prostate cancer cells. Jeong CW; Yoon CY; Jeong SJ; Hong SK; Byun SS; Kwak C; Lee SE Urol Oncol; 2013 Nov; 31(8):1448-56. PubMed ID: 22537539 [TBL] [Abstract][Full Text] [Related]
38. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway. Amir S; Golan M; Mabjeesh NJ Mol Cancer Res; 2010 May; 8(5):643-52. PubMed ID: 20407014 [TBL] [Abstract][Full Text] [Related]
39. MiR-182 promotes glucose metabolism by upregulating hypoxia-inducible factor 1α in NSCLC cells. Wang M; Wang W; Wang J; Zhang J Biochem Biophys Res Commun; 2018 Oct; 504(2):400-405. PubMed ID: 29894685 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-responsive miR-141-3p is involved in the progression of breast cancer via mediating the HMGB1/HIF-1α signaling pathway. Sun S; Ma J; Xie P; Wu Z; Tian X J Gene Med; 2020 Oct; 22(10):e3230. PubMed ID: 32436353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]